Home/Avocet Bio/Elisabeth Zeisberg
EZ

Elisabeth Zeisberg

CEO & Co-founder

Avocet Bio

Therapeutic Areas

Avocet Bio Pipeline

DrugIndicationPhase
CRISPR/Cas13 Antiviral PlatformBroad-spectrum RNA virus infections (e.g., Coronaviruses)Pre-clinical